Bone marrow plasma cells 20% or greater discriminate presentation, response, and survival in AL amyloidosis-Reference-Cited by-同舟云学术

Bone marrow plasma cells 20% or greater discriminate presentation, response, and survival in AL amyloidosis

Published:2019-11-22 Issue:4 Volume:34 Page:1135-1143
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Muchtar Eli^ORCID,Gertz Morie A.,Kourelis Taxiarchis V.,Sidana Surbhi^ORCID,Go Ronald S.^ORCID,Lacy Martha Q.,Buadi Francis K.,Dingli David,Hayman Suzanne R.,Kapoor Prashant,Leung Nelson^ORCID,Fonder Amie,Hobbs Miriam,Lisa Hwa Yi,Gonsalves Wilson,Warsame Rahma,Russell Stephen,Lust John A.,Lin Yi,Zeldenrust Steven,Rajkumar S. Vincent,Kyle Robert A.,Kumar Shaji K.^ORCID,Dispenzieri Angela

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/s41375-019-0655-x.pdf

Reference25 articles.

1. Merlini G, Dispenzieri A, Sanchorawala V, Schonland SO, Palladini G, Hawkins PN, et al. Systemic immunoglobulin light chain amyloidosis. Nat Rev Dis Prim. 2018;4:38.

2. Tovar N, Rodriguez-Lobato LG, Cibeira MT, Magnano L, Isola I, Rosinol L, et al. Bone marrow plasma cell infiltration in light chain amyloidosis: impact on organ involvement and outcome. Amyloid. 2018;25:79–85.

3. Muchtar E, Gertz MA, Kumar SK, Lacy MQ, Dingli D, Buadi FK, et al. Improved outcomes for newly diagnosed AL amyloidosis between 2000 and 2014: cracking the glass ceiling of early death. Blood. 2017;129:2111–9.

4. Kourelis TV, Kumar SK, Gertz MA, Lacy MQ, Buadi FK, Hayman SR, et al. Coexistent multiple myeloma or increased bone marrow plasma cells define equally high-risk populations in patients with immunoglobulin light chain amyloidosis. J Clin Oncol. 2013;31:4319–24.

5. Rajkumar SV, Dimopoulos MA, Palumbo A, Blade J, Merlini G, Mateos MV, et al. International myeloma working group updated criteria for the diagnosis of multiple myeloma. Lancet Oncol. 2014;15:e538–548.

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long‐term outcomes of renal AL amyloidosis patients undergoing autologous stem cell transplantation: Validating the performance of the renal staging system;American Journal of Hematology;2024-08-29

2. A bibliometric analysis of light chain amyloidosis from 2005 to 2024: research trends and hot spots;Frontiers in Medicine;2024-07-30

3. Treatment of AL amyloidosis in the era of novel immune and cellular therapies;Frontiers in Oncology;2024-06-28

4. A real‐life study of daratumumab combinations in newly diagnosed patients with light chain (AL) amyloidosis;Hematological Oncology;2024-06-02

5. AL amyloidosis: Singapore Myeloma Study Group consensus guidelines on diagnosis, treatment and management;Annals of the Academy of Medicine, Singapore;2023-11-29